Annual report pursuant to Section 13 and 15(d)

Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)

v3.22.2.2
Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Balance $ 1,562,971    
Balance 1,701,770 $ 1,562,971  
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]      
Balance (6,193) (13,253) $ (9,537)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne 9,403 100 (7,179)
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) 4,859 6,960 3,464
Balance 8,069 (6,193) (13,253)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]      
Balance (51,098) (83,946) (73,983)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne (32,171) 32,848 (9,963)
Balance (83,269) (51,098) (83,946)
AOCI Attributable to Parent [Member]      
Balance (57,291) (97,199) (83,521)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne (22,768) 32,948 (17,142)
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) 4,859 6,960 3,464
Balance $ (75,200) $ (57,291) $ (97,199)